$XOMA..Ph3 EYEGUARD-B data (Gevokizumab/Behçet’s uveitis) in JUNE. Ph3 EYEGUARD-A & C data (Gevokizumab/acute/controlled NIU) in 2H (h/t @TomSilver39)